Saturday, 31 October 2026European Markets

MYHOTELMATCH Stock Over 9% Down So Far On Wednesday

Loading stream...

the attention of today's trading session has been attracted by fluctuations in myhotelmatch's (mhm.pa) stock price, which dropped 9.87% to eur2.10, whilst the cac 40 index saw a gain of 1.46% to eur7,375.69. this could be significant for investors given that myhotelmatch has seen losses for two consecutive days in an otherwise rising market.

about myhotelmatch

myhotelmatch is a france-based company that employs ai to manage an online hotel reservation platform. however, its share price has recently seen a significant drop, falling 48.45% below its 52-week high of eur0.04 in 2017. this leaves stockholders questioning whether the decline is due to internal problems with myhotelmatch or a reflection of broader external factors.

myhotelmatch's financial situation

from a financial perspective, myhotelmatch's current status is not positive, as mirrored by its trailing 12-month earnings per share of eur-0.03. these negative numbers often implicate a company's failure to generate profits and throw a shadow over its financial sustainability.

stochastic oscillator analysis

stochastic oscillator analysis suggests that mhm.pa shares might be undervalued at the moment. oversold conditions frequently trigger a technical price correction, providing potential investors with a chance to benefit.

myhotelmatch's price volatility

myhotelmatch's price volatility is also visible in its average volatility rates. over the course of the past week, month and quarter, average intraday shifts were approximately 1.01% for week 1, 0.233% for month 1, and 4.366% for quarter 3. this level of instability or risk might suggest potential uncertainty or risk in its future performance.

current stock value of myhotelmatch

the present stock value of myhotelmatch at eur2.10 draws a stark contrast to its 52-week high of eur0.04, implying either an oversight or altered views about performance. these findings underscore the need for accurate data when interpreting stock trends.

more news about myhotelmatch (mhm.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com